Therapeutic Cataract & Refractive

Justin Schweitzer, OD, FAAO, reports that glaucoma therapy is quickly moving to more innovative and targeted ways to treat glaucoma and lower the patient treatment burden.

Postoperative scenario tracks potential complications.

Results from a parallel arm study suggest opportunity to expand on visual performance and productivity improvement.

Evaluating patients’ eyelids before cataract and refractive surgery is crucial, as ptosis can create unwanted adverse effects and alter outcomes.

AcuFocus's IC-8 Apthera IOL features a proprietary small aperture technology that filters out peripheral defocused light and allows only focused light to reach the retina.

Bobby Saenz, OD, MS, FAAO, discusses his AOA 2022 presentation, "Extended Depth of Focus Lenses and Drops."

Early diagnosis enables cross-linking treatment before significant vision loss.

Posterior chamber pIOLs should be considered for patients in which other refractive surgeries may not be an option and as an reversible alternative with fewer complications.

This far-less-understood option can fill multiple needs for a practice.

Practices must efficiently integrate optometry and ophthalmology, delegating appropriate care to the proper specialist, in order to ensure patients’ total eye care needs are best met.

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

Physicians share tales of creative workarounds to cope with this condition.

Research also highlights the top factors that lead to care, which can be used to improve parents' uptake of sight-saving surgery for their children.

Test your knowledge!

Expected findings in follow-up, management, and potential complications.

Why managing progressive keratoconus during pregnancy can be a challenge

Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.

Educate providers, build a referral network, and add tools of the trade

Dr. Jennifer Lyerly talks vision therapy with Dr. Joanna Carter. Take a listen!

New drug from Gensight Biologics hits pipeline

Eye physicals should be full-scope

Keep the specific needs of this patient population in mind as more patients return to the office

LASIK deserves the hype, but it’s not for everyone

Cross-sectional structures of the bulbar conjunctival tissue can be accurately measured